The RGT Capital Management Ltd. Invests $1236000 in Johnson & Johnson (JNJ)

On Wednesday, Johnson & Johnson (NYSE:JNJ) stock opened its trade at $119.28 and after floating in a range of $119.25 to $119.77, settled at $119.52. Vetr's target price would suggest a potential upside of 2.33% from the company's current price. Investors who are keeping close eye on the stock of Johnson & Johnson (NYSE:JNJ) established that the company was able to keep return on investment at - in the trailing twelve month while Reuters data showed that industry's average stands at 13.47 and sector's optimum level is 12.97. Tesco Pension Investment Ltd bought a new position in shares of Johnson & Johnson during the third quarter worth about $148,524,000. Lenox Wealth Management Inc. now owns 972 shares of the company's stock valued at $118,000 after buying an additional 190 shares during the last quarter. According to their observations and findings, the stock could provide a high EPS of $1.88/share and a Low EPS of $1.73/share. Finally, DZ BANK AG Deutsche Zentral Genossenschafts Bank Frankfurt am Main purchased a new stake in Johnson & Johnson during the fourth quarter valued at about $277,294,000. Hedge funds and other institutional investors own 65.30% of the company's stock. The firm has a 50-day moving average of $114.45 and a 200-day moving average of $117.02. On a price appreciation basis over the past 12 months, the stock returned 17.23%. The company's market cap is $325.54 Billion.

Johnson & Johnson (NYSE:JNJ) reported its last quarter results on 01/24/2017. Analysts had expected Johnson & Johnson (NYSE:JNJ) to post net income of about $1.56 per share on $18,275.20M in revenue. The firm's quarterly revenue was up 1.7% compared to the same quarter previous year. During the same quarter in the previous year, the firm earned $1.44 EPS. On average, equities research analysts forecast that Johnson & Johnson will post $7.04 EPS for the current fiscal year.

The company also recently declared a quarterly dividend, which will be paid on Tuesday, March 14th. Investors of record on Tuesday, February 28th will be given a dividend of $0.80 per share. The ex-dividend date is Friday, February 24th. This represents a $3.20 annualized dividend and a yield of 2.68%. Johnson & Johnson's dividend payout ratio (DPR) is 54.42%.

A number of analysts have recently issued reports on JNJ shares. Goldman Sachs Group, Inc. The consensus price target (PT) of $125.06 means that the market expects Company shares to increase by 4.5% in the short run. Fundsmith LLP now owns 3,704,693 shares of the company's stock worth $449,379,000 after buying an additional 719,532 shares during the last quarter. Credit Suisse Group restated a "hold" rating on shares of Johnson & Johnson in a research note on Tuesday, December 20th.

Johnson & Johnson (NYSE:JNJ) topped its 52-week high price of $126.07 on Jul 20, 2016 and 52-Week Low Price of $104.77 on Feb 25, 2016. Out of 0 brokerage recommendations, 0 gave a Strong Buy, 0 issued a Buy, 0 issued Hold, 0 rated Under-perform and 0 issued a Sell. The company has an average rating of "Hold" and a consensus price target of $122.92.

In related news, VP Paulus Stoffels sold 22,000 shares of the business's stock in a transaction that occurred on Wednesday, February 15th. Stock exchanged hands with the total volume of 2.04 Million shares, as contrast to its average volume of 2.26 Million shares. Following the transaction, the Exec VP, Chief Scientific Off is left with a stake of 127,650 shares, now valued at $15256728. The insider owns 259,978 shares as of less than 0.1%, now worth $31072570.56.

  • Zachary Reyes